CVS Health CorporationCVSNYSE
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
5Y CAGR+29.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+29.3%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 325.88% |
| Q3 2025 | -58.04% |
| Q2 2025 | -58.36% |
| Q1 2025 | 144.95% |
| Q4 2024 | 349.66% |
| Q3 2024 | -124.12% |
| Q2 2024 | -37.00% |
| Q1 2024 | 286.00% |
| Q4 2023 | -197.05% |
| Q3 2023 | -54.03% |
| Q2 2023 | -20.57% |
| Q1 2023 | 481.05% |
| Q4 2022 | -121.40% |
| Q3 2022 | 67.61% |
| Q2 2022 | 52.76% |
| Q1 2022 | -11.04% |
| Q4 2021 | -27.46% |
| Q3 2021 | -5.58% |
| Q2 2021 | 102.18% |
| Q1 2021 | -18.92% |
| Q4 2020 | 90.34% |
| Q3 2020 | -73.68% |
| Q2 2020 | 115.40% |
| Q1 2020 | 25.47% |
| Q4 2019 | -10.04% |
| Q3 2019 | -45.15% |
| Q2 2019 | 174.02% |
| Q1 2019 | -21.42% |
| Q4 2018 | 125.98% |
| Q3 2018 | -62.61% |
| Q2 2018 | 24.59% |
| Q1 2018 | 1831.62% |
| Q4 2017 | -105.21% |
| Q3 2017 | 30.62% |
| Q2 2017 | -43.42% |
| Q1 2017 | 66.57% |
| Q4 2016 | -46.09% |
| Q3 2016 | 138.86% |
| Q2 2016 | -32.47% |
| Q1 2016 | -31.70% |